AVENUE THERAPEUTICS INC
For the period ended Jun 24, 2024. Filed Jun 26, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jun 24, 2024 · Filed Jun 26, 2024
Use the contents to explore the available documents and sections.
Contents
Proposal
Proposal 1
The votes with respect to the election of six directors to hold office until the 2025 annual meeting of stockholders were as follows:
| Director | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| Jay Kranzler, M.D., Ph.D. | 704,444 | 20,092 | 157,517 |
| Faith Charles | 704,702 | 19,834 | 157,517 |
| Neil Herskowitz | 704,291 | 20,245 | 157,517 |
| Alexandra MacLean, M.D. | 705,060 | 19,476 | 157,517 |
| Curtis Oltmans | 704,494 | 20,042 | 157,517 |
| Lindsay A. Rosenwald, M.D. | 704,169 | 20,367 | 157,517 |
Proposal 2
The vote on the proposal to ratify the selection of KPMG LLP as Avenue’s independent registered accounting firm for the year ending December 31, 2024 was as follows:
| Total Votes For | Total Votes Against | Abstentions |
|---|---|---|
| 838,846 | 43,097 | 110 |
Proposal 3
The vote on the 2015 Plan Amendment was as follows:
| Total Votes For | Total Votes Against | Abstentions | Broker Non-Votes |
|---|---|---|---|
| 676,517 | 31,837 | 16,182 | 157,517 |
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The following exhibit is furnished herewith:
| Exhibit Number | Description |
| 10.1 | Amendment to the Avenue Therapeutics, Inc. 2015 Incentive Plan. |
| 104 | Cover Page Interactive Data File (embedded within Inline XBRL document) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.